Penumbra, Inc.
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need.
Follow us on Twitter @Penumbrainc @PenVascular @PenNeuro
Follow us on LinkedIn
Visit our website at www.penumbrainc.com
The STRIDE Study for Acute Limb Ischemia, 30-Day Results
By
Penumbra, Inc.
FEATURING
Thomas Maldonado
By
Penumbra, Inc.
FEATURING
Thomas Maldonado
For US HCPs: Presented at VAM 2023, the STRIDE Study 30-day results show that the use of Penumbra's Indigo aspiration system in lower-extremity acute limb ischemia is safe and effective with high target limb salvage and low mortality rates. National Principal Investigator, Dr. Tom Maldonado, shares the key results.
Login to view comments.
Click here to Login
